CAR T-Cell Therapy in Multiple Myeloma: Current Evidence and Guidance to Support Optimal Integration Into Care

Deepen your understanding of CAR T-cell therapy in multiple myeloma vs other anticancer treatments, including the current evidence, toxicity management, and coordination strategies with specialized treatment centers, through on-demand webcasts with accompanying slides and an expert-written ClinicalThought.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

Supporters

Supported by educational grants from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC and Legend Biotech USA, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Legend Biotech USA Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner